AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,958 | -29.8% | 161 | -27.5% | 0.00% | -100.0% |
Q2 2023 | $2,789 | +13.3% | 222 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $2,462 | -9.2% | 222 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $2,711 | +35.6% | 222 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $2,000 | 0.0% | 222 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $2,000 | +100.0% | 222 | +217.1% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 70 | -41.7% | 0.00% | – |
Q3 2021 | $1,000 | – | 120 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |